Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Interstitial Pulmonary Fibrosis”

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 0 results

Testing effectiveness (Phase 2)Study completedNCT00162760
What this trial is testing

Treatment of Idiopathic Pulmonary Fibrosis With Thalidomide

Who this might be right for
Idiopathic Pulmonary Fibrosis (IPF)
Johns Hopkins University 19
Testing effectiveness (Phase 2)Active Not RecruitingNCT06329401
What this trial is testing

A Study Evaluating the Safety and Efficacy of Inhaled AP01 in Participants With Progressive Pulmonary Fibrosis

Who this might be right for
Pulmonary FibrosisProgressive Pulmonary FibrosisPulmonary Fibrosis Secondary to Systemic Sclerosis+7 more
Avalyn Pharma Inc. 375
Post-approval studies (Phase 4)Ended earlyNCT01321996
What this trial is testing

68Ga-DOTA-NOC PET/CT in Patients With Idiopathic Pulmonary Fibrosis

Who this might be right for
Idiopathic Pulmonary Fibrosis
IRCCS Azienda Ospedaliero-Universitaria di Bologna 29
Early research (Phase 1)Study completedNCT05817240
What this trial is testing

A Drug-Drug Interaction Study of ENV-101 (Taladegib) on Nintedanib Pharmacokinetics in Healthy Subjects

Who this might be right for
Idiopathic Pulmonary Fibrosis
Endeavor Biomedicines, Inc. 21
Not applicableUnknownNCT03670576
What this trial is testing

It's Not JUST Idiopathic Pulmonary Fibrosis Study

Who this might be right for
Interstitial Lung DiseaseIdiopathic Pulmonary Fibrosis
University of Nottingham 250
Large-scale testing (Phase 3)Study completedNCT00662038
What this trial is testing

Open-Label Study of the Long Term Safety of Pirfenidone in Patients With Idiopathic Pulmonary Fibrosis (IPF)

Who this might be right for
Idiopathic Pulmonary Fibrosis
Genentech, Inc. 1,058
Large-scale testing (Phase 3)Ended earlyNCT04419558
What this trial is testing

Zephyrus II: Efficacy and Safety Study of Pamrevlumab in Participants With Idiopathic Pulmonary Fibrosis (IPF)

Who this might be right for
Idiopathic Pulmonary Fibrosis
Kyntra Bio 372
Large-scale testing (Phase 3)Active Not RecruitingNCT06238622
What this trial is testing

A Follow-up Study to Test Long-term Treatment With Nerandomilast in People With Pulmonary Fibrosis Who Took Part in a Previous Study With Nerandomilast

Who this might be right for
Idiopathic Pulmonary FibrosisProgressive Pulmonary Fibrosis
Boehringer Ingelheim 1,666
Not applicableLooking for participantsNCT03478553
What this trial is testing

The Genetics of Pulmonary Fibrosis

Who this might be right for
Idiopathic Pulmonary Fibrosis (IPF)
University of Colorado, Denver 1,000
Not applicableUnknownNCT05449431
What this trial is testing

Comparison of the 1-min Sit-to-Stand Test to the 6-minute Walk Test in the Respiratory Functional Assessment of Pulmonary Fibrosis

Who this might be right for
Idiopathic Pulmonary Fibrosis
Fondation Hôpital Saint-Joseph 36
Large-scale testing (Phase 3)Study completedNCT05415137
What this trial is testing

Efficacy and Safety of Intravenous Efzofitimod in Patients With Pulmonary Sarcoidosis

Who this might be right for
Pulmonary Sarcoidosis
aTyr Pharma, Inc. 268
Not applicableNot Yet RecruitingNCT07728448
What this trial is testing

Predictors of Pulmonary Embolism in Interstitial Lung Disease With Worsening Symptoms

Who this might be right for
Pulmonary EmbolismInterstitial Lung DiseaseIdiopathic Pulmonary Fibrosis+1 more
Assiut University 70
Not applicableStudy completedNCT04430491
What this trial is testing

To Evaluate the Use of Radiomics to Classify Between Idiopathic Pulmonary Fibrosis and Interstitial Lung Disease

Who this might be right for
Interstitial Lung DiseaseIdiopathic Pulmonary FibrosisUsual Interstitial Pneumonia
Maastricht University 300
Testing effectiveness (Phase 2)Study completedNCT02085018
What this trial is testing

Pilot Trial Of Omeprazole in Idiopathic Pulmonary Fibrosis (IPF)

Who this might be right for
Idiopathic Pulmonary Fibrosis
Newcastle-upon-Tyne Hospitals NHS Trust 45
Not applicableStudy completedNCT04170062
What this trial is testing

Oxygen Savings With Administered Oxygen and High Flow Ambient Air At Rest

Who this might be right for
Pulmonary Disease, Chronic ObstructiveLung Diseases, InterstitialPulmonary Fibrosis+3 more
Johns Hopkins University 11
Not applicableUnknownNCT04619199
What this trial is testing

Influence of Socioeconomic and Environmental Factors on the Natural History of Idiopathic Pulmonary Fibrosis

Who this might be right for
Idiopathic Pulmonary FibrosisPulmonary DiseasePulmonary Medicine
Assistance Publique - Hôpitaux de Paris 200
Not applicableUnknownNCT05174741
What this trial is testing

Pulmonary Rehabilitation in Non-chronic Obstructive Pulmonary Disease Patients.

Who this might be right for
PneumoniaPulmonary FibrosisTuberculosis+2 more
Riphah International University 20
Not applicableUnknownNCT04990531
What this trial is testing

Low-field Magnetic Resonance Imaging of Pediatric COVID-19

Who this might be right for
Sars-CoV-2 InfectionLung FibrosisCovid19
University of Erlangen-Nürnberg Medical School 68
Not applicableLooking for participantsNCT06615492
What this trial is testing

Routine vs On-demand ECMO for Lung Transplantation

Who this might be right for
Respiratory FailureInterstitial Lung Disease (ILD)Pulmonary Fibrosis+1 more
Centre hospitalier de l'Université de Montréal (CHUM) 218
Testing effectiveness (Phase 2)Looking for participantsNCT05139719
What this trial is testing

Explore the Therapeutic Effect of HEC585 on Delaying Forced Vital Capacity (FVC) Decline and Tolerance in Progressive Fibrosing Interstitial Lung Disease (PF-ILD) Patients

Who this might be right for
Progressive Fibrosing Interstitial Lung Disease (PF-ILD) / Progressive Pulmonary Fibrosis (PPF)
Sunshine Lake Pharma Co., Ltd. 110
Next Page